Why does Nanobiotix (NBTX) publish its voting rights and share capital figures?

Nanobiotix publishes voting rights and share capital to comply with French market regulations. According to Nanobiotix, this disclosure follows article L.233-8 II of the French Commercial Code and AMF General Regulation article 223-16 to inform shareholders and investors.

Voting Rights and Shares Capital of the Company

Q: How many Nanobiotix (NBTX) shares were outstanding on May 31, 2026?

Nanobiotix reported 50,807,903 shares outstanding on May 31, 2026. According to Nanobiotix, this figure reflects its current share capital listed on Euronext Paris and Nasdaq under ISIN code FR0011341205.

Q: What are the total voting rights for Nanobiotix (NBTX) as of May 31, 2026?

Nanobiotix reported 54,304,858 theoretical voting rights as of May 31, 2026. According to Nanobiotix, these rights represent the maximum voting power attached to its 50,807,903 shares under French market regulations.

Q: What are the exercisable voting rights of Nanobiotix (NBTX) on May 31, 2026?

Nanobiotix reported 54,282,740 exercisable voting rights as of May 31, 2026. According to Nanobiotix, this number reflects voting rights that can actually be exercised, slightly below the theoretical total of 54,304,858.

Q: On which markets is Nanobiotix (NBTX) listed and what is its ISIN code?

Nanobiotix shares trade on Euronext Paris and Nasdaq. According to Nanobiotix, its securities are identified under ISIN code FR0011341205, with Bloomberg ticker NANO:FP and Reuters code NANO.PA for investors tracking the stock.

Nanobiotix (Nasdaq: NBTX) reported its share capital and voting rights as of May 31, 2026, in line with French market regulations.

Rhea-AI Impact

(Moderate)

Rhea-AI Sentiment

(Neutral)

Rhea-AI Summary

Nanobiotix (Nasdaq: NBTX) reported its share capital and voting rights as of May 31, 2026, in line with French market regulations.

The company had 50,807,903 shares outstanding, with 54,304,858 theoretical and 54,282,740 exercisable voting rights on Euronext Paris and Nasdaq.

Argus Jun 8 session

+1.18% close to close Open Argus

Details

News Market Reaction – NBTX

On Jun 8, the first trading day after this news, NBTX closed 1.18% above the previous close.

Data tracked by StockTitan Argus for the Jun 8 session.

Market Context

This announcement updates the company’s capital structure, confirming 50,807,903 shares outstanding ...

Analysis

This announcement updates the company’s capital structure, confirming 50,807,903 shares outstanding and 54,304,858 theoretical voting rights as of May 31, 2026, under French transparency rules. In the context of recent global equity offerings and index inclusion, investors may track how the enlarged share base interacts with future financings and clinical milestones. Key metrics to watch include share count changes, cash runway disclosures, and further regulatory or trial updates tied to JNJ-1900 (NBTXR3) and Nanoprimer.

Key Figures

Shares outstanding: 50,807,903 Theoretical voting rights: 54,304,858 Exercisable voting rights: 54,282,740 +5 more

Shares outstanding: 50,807,903; Share capital as of May 31, 2026
Theoretical voting rights: 54,304,858; Total voting rights, theoretical, May 31, 2026
Exercisable voting rights: 54,282,740; Total voting rights, exercisable, May 31, 2026
Current price: $36.91; Pre-news close, Nasdaq NBTX
52-week high: $57.14; 52-week trading range
52-week low: $4.10; 52-week trading range
Market cap: $1,785,132,061; Pre-news market capitalization
20-day average volume: 75,046; Average daily volume over last 20 sessions

Historical Context

5 past events · Latest: Jun 02

5 events

Jun 02
Ops/financial update

24h Move

-4.2%

Q1 2026 operational and financial progress, including cash runway into 2029.
Jun 02
Index inclusion

24h Move

-3.3%

Addition to Euronext Tech Leaders segment and index to boost visibility.
May 26
Global offering close

24h Move

-0.7%

Closing of global offering raising about $100M in gross proceeds.
May 22
Over-allotment exercise

24h Move

-0.5%

Full exercise of over-allotment option, lifting offering gross proceeds to ~$100M.
May 21
Offering pricing

24h Move

-6.9%

Pricing of oversubscribed €85m global follow-on equity offering.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

voting rights, isin code

2 terms

voting rights regulatory

"Total number of voting rights"

Voting rights are the ability of shareholders to have a say in important company decisions, like choosing leaders or approving big changes. They matter because they give owners a voice in how the company is run, similar to how voters influence elections, ensuring the company acts in shareholders’ interests.

isin code regulatory

"ISIN code: FR0011341205"

An ISIN code is a unique identifier for a specific financial asset, like a stock or bond, similar to a product's barcode. It helps investors, traders, and banks quickly and accurately find and track that asset across different markets worldwide. This makes buying, selling, and managing investments more organized and reliable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

06/05/2026 - 04:15 PM

In accordance with articles L.233-8 II of the French Commercial Code and 223-16 of the General Regulation of the French Financial Markets Authority (Autorité des Marchés Financiers)

PARIS, June 05, 2026 (GLOBE NEWSWIRE) --
Market: Euronext Paris / Nasdaq
Euronext Compartment: B
ISIN code: FR0011341205
Nasdaq: NBTX
Bloomberg: NANO:FP
Reuters: NANO.PA
Website: www.nanobiotix.com

Date	Number of Shares Outstanding	Total number of voting rights
		Total voting rights, theoretical¹	Total voting rights, exercisable²
May 31, 2026	50,807,903	54,304,858	54,282,740

About NANOBIOTIX

Nanobiotix is a late-stage clinical biotechnology company pioneering disruptive, physics-based therapeutic approaches to revolutionize treatment outcomes for millions of patients; supported by people committed to making a difference for humanity. The Company’s philosophy is rooted in the concept of pushing past the boundaries of what is known to expand possibilities for human life.

Incorporated in 2003, Nanobiotix is headquartered in Paris, France and is listed on Euronext Paris since 2012 and on the Nasdaq Global Select Market in New York City since December 2020. The Company has a subsidiary in Cambridge, Massachusetts (United States).

Nanobiotix is the owner of more than 30 patent families associated with three (3) nanotechnology platforms with applications in 1) oncology; 2) bioavailability and biodistribution; and 3) disorders of the central nervous system.

For more information about Nanobiotix, visit us at www.nanobiotix.com or follow us on LinkedIn and Twitter.

_______________________________
¹ The total number of theoretical (or “gross”) voting rights is used as the basis for calculating threshold crossings. In accordance with Article 223-11 of the AMF General Regulations, this number is calculated on the basis of all shares to which voting rights are attached, including those for which voting rights have been suspended.

² The total number of exercisable at a shareholders’ meeting (or “net”) voting rights is calculated without taking into account shares for which voting rights have been suspended as shares held in treasury by the Company. It is released in order to ensure that the public is properly informed.

Contacts

Nanobiotix
Communications Department Brandon Owens VP, Communications +1 (617) 852-4835 contact@nanobiotix.com	Investor Relations Department Joanne Choi VP, Investor Relations (US) +1 (713) 609-3150 Ricky Bhajun Director, Investor Relations (EU) investors@nanobiotix.com
Media Relations
France – HARDY Caroline Hardy +33 06 70 33 49 50 carolinehardy@outlook.fr	Global – uncapped Becky Lauer +1 (646) 286-0057 uncappednanobiotix@uncappedcommunications.com

Attachment

2026-06-05 -- NBTX -- Voting Rights & Shares Capital -- FINAL

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many Nanobiotix (NBTX) shares were outstanding on May 31, 2026?

Nanobiotix reported 50,807,903 shares outstanding on May 31, 2026. According to Nanobiotix, this figure reflects its current share capital listed on Euronext Paris and Nasdaq under ISIN code FR0011341205.

What are the total voting rights for Nanobiotix (NBTX) as of May 31, 2026?

Nanobiotix reported 54,304,858 theoretical voting rights as of May 31, 2026. According to Nanobiotix, these rights represent the maximum voting power attached to its 50,807,903 shares under French market regulations.

What are the exercisable voting rights of Nanobiotix (NBTX) on May 31, 2026?

Nanobiotix reported 54,282,740 exercisable voting rights as of May 31, 2026. According to Nanobiotix, this number reflects voting rights that can actually be exercised, slightly below the theoretical total of 54,304,858.

On which markets is Nanobiotix (NBTX) listed and what is its ISIN code?

Nanobiotix shares trade on Euronext Paris and Nasdaq. According to Nanobiotix, its securities are identified under ISIN code FR0011341205, with Bloomberg ticker NANO:FP and Reuters code NANO.PA for investors tracking the stock.

Voting Rights and Shares Capital of the Company

Rhea-AI Summary

Positive